Therefore, it is possible that rifampin may alter miRNA expression, which in turn affects the expression of the drug metabolizing enzyme gene CYP2E1. MiR-186 was found to regulate two genes (CEBPA, CREBBP), which were associated with cancer pathways. The gene discussed is CREBBP; the disease is cancer.